We can no longer ignore the potential of psychedelic drugs to treat depression
Psilocybin ( or “magic mushrooms”) can be used to assist psychotherapy for difficult-to-treat depression, making a significant difference when conventional antidepressants and talking therapy have not
Monday, June 8, 2020
The world is experiencing a devastating physical health emergency. But the coronavirus pandemic has also seen a renewed focus on our psychological wellbeing. Loneliness, uncertainty and grief may be intensifying an already acute mental health crisis, and in the US there has been a 20% spike in the number of prescriptions for antidepressant and anti-anxiety drugs during lockdown. Demand for key antidepressants is threatening to exceed supply in the UK – where prescriptions have already more than doubled over the last decade. At Imperial College we’ve been comparing psilocybin to conventional drugs – and the results are potentially game-changing.